Rare diseases
Investigational molecules
Locations
Back to Denmark1 429 clinical trials in Copenhagen, Denmark across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Study on the Long-Term Safety of PTC923 (Sepiapterin) for Patients with Phenylketonuria
DenmarkStudy of Pembrolizumab and Enfortumab Vedotin with Surgery vs. Surgery Alone for Patients with Muscle-Invasive Bladder Cancer Who Cannot or Choose Not to Use Cisplatin
DenmarkStudy on Siplizumab and Rabbit Anti-Thymocyte Globulin for Preventing Rejection in New Kidney Transplant Patients
AustriaStudy of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma
DenmarkStudy of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery
DenmarkStudy of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure
DenmarkStudy on the Safety and Effectiveness of Ocrelizumab vs. Fingolimod for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis
DenmarkStudy on the Effectiveness and Safety of AZD4604 for Adults with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA
DenmarkStudy on How Concizumab Works for Patients with Hemophilia A or B Without Inhibitors
DenmarkStudy on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
DenmarkStudy on the Effects of a Higher Dose of Ocrelizumab for Adults with Relapsing Multiple Sclerosis
DenmarkStudy of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Clinical trial activity in København includes cardiovascular diseases, with studies focused on acute heart failure. The research is aimed at improving treatment choices and helping clinicians better manage fluid overload and treatment response.
These trials support more effective day-to-day management of patients with unstable heart conditions.
Research in digestive system diseases is centered on liver cirrhosis and its complications, especially ascites. The main purpose is to improve treatment planning and identify which patients are most likely to benefit from supportive therapy.
This work may help refine care for people with advanced liver disease.
Trials in the field of neoplasms are examining localised dMMR colon cancer. The research is focused on assessing treatment effectiveness and understanding how well patients respond to newer cancer approaches.
These studies aim to strengthen precision treatment for selected colorectal cancer patients.
Clinical research in nervous system diseases involves acute ischemic stroke. The goal is to improve urgent stroke care by comparing treatment approaches and their impact on early neurological recovery.
These trials are designed to support faster, more effective treatment decisions after stroke.
Research in virus diseases includes work on chronic hepatitis B infection, with studies exploring immune-based approaches and treatment effects. The overall aim is to improve control of long-term viral infection and related liver health.
These trials reflect active interest in advancing antiviral research in Denmark.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
